Connect your AI

Alumis Inc. ALMS Total Current Assets

Total Current Assets at other companies

Bristol-Myers SquibbBMY

$27.21B-11.6%

AmgenAMGN

$31.48B+16.9%

Oruka Therapeutics, Inc.ORKA

$395.25M+12.3%

Celldex TherapeuticsCLDX

$459.22M-33.8%

ImmunomeIMNM

$594.31M+83.9%

Nektar TherapeuticsNKTR

$589.04M+156%

Other financials

Income statement

Revenue$1.7M-90.0%

Operating income-$98.4M+3.1%

Net income-$93.1M+6.0%

EPS (diluted)-$0.74+59.3%

Balance sheet

Cash & equivalents$63.9M-50.3%

Total debt$35.7M+1,881%

Total equity$567.0M+237%

Total assets$671.6M+157%

Cash flow

Operating cash flow-$87.1M-8.4%

CapEx$164.0K+343%

Free cash flow-$87.2M-8.5%

Valuation

Market cap$3.12B+739%

Enterprise value$3.1B+1,238%

P/S371.9×—

Profitability

Operating margin-5,364%—

Net margin-2,825.7%—

FCF margin-4,487.4%—

Returns & leverage

Return on equity-64.6%—

Debt / equity0.1×+0.1×

Current ratio7.5×+3.8×

Where this comes from

Reported directly by Alumis Inc. in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The official record: Alumis Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alumis Inc.'s total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Alumis Inc.'s total current assets?: Alumis Inc. (ALMS) reported total current assets of $532.41M in Q1 2026.
How has Alumis Inc.'s total current assets changed year-over-year?: Alumis Inc.'s total current assets increased by 136.1% year-over-year, from $225.53M to $532.41M.
What is the long-term trend for Alumis Inc.'s total current assets?: Over 2 years (2023 to 2025), Alumis Inc.'s total current assets has grown at a 144.2% compound annual growth rate (CAGR), from $53.36M to $318.23M.
What does total current assets mean?: The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.